Qi Ma
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Qi Ma has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Bin Wu
Department of Neurology and National Research Center for Aging and Medicine & National Center for Neurological Disorders, State Key Laboratory of Brain Function and Disorders, Huashan Hospital, Fudan University, Shanghai, China
1 shared publication - Bo Wang
Institute of Neuroscience, Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences, Shanghai, China
1 shared publication - Haibo Zhou
Institute of Neuroscience, State Key Laboratory of Neuroscience, Key Laboratory of Primate Neurobiology, Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences, Shanghai, China
1 shared publication - Jianrong Wu
Shanghai Institute of Ultrasound in Medicine, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai 200233, China
1 shared publication - Liansheng Zhang
Institute of Neuroscience, State Key Laboratory of Neuroscience, Key Laboratory of Primate Neurobiology, Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences, Shanghai, China
1 shared publication Meimei Zhang
Genemagic Biosciences Co., Ltd., Shanghai, China
1 shared publication
Latest Publications
- 23 April 2026
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 392 (6796) , eadw2156
Mapping transcription factor functions in astrocytes using in vivo gain-of-function Perturb-seq
An in vivo approach combining high-throughput screening with cell type–specific readouts could enable elucidation of genotype-phenotype relationships in complex tissues. We developed an in vivo gain-of-function Perturb-seq platform, termed iGOF–Perturb-seq, to build a functional atlas of ~1000 transcription factors (TFs) in astrocytes, a cell type essential to many brain functions. We then identified cofunctional modules, annotated uncharacterized TFs, and predicted disease-associated TF clusters. Furthermore, iGOF–Perturb-seq performed in a mouse neuroinflammatory model identified Ferd3l as a therapeutic candidate, and astrocyte-specific overexpression of Ferd3l alleviated Alzheimer’s disease symptoms in mice. This study provides resources for understanding gene regulation and disease mechanisms in vivo and for identifying potential therapeutic targets for different brain diseases.
- 23 April 2026
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 392 (6796) , eadw2156
Mapping transcription factor functions in astrocytes using in vivo gain-of-function Perturb-seq
An in vivo approach combining high-throughput screening with cell type–specific readouts could enable elucidation of genotype-phenotype relationships in complex tissues. We developed an in vivo gain-of-function Perturb-seq platform, termed iGOF–Perturb-seq, to build a functional atlas of ~1000 transcription factors (TFs) in astrocytes, a cell type essential to many brain functions. We then identified cofunctional modules, annotated uncharacterized TFs, and predicted disease-associated TF clusters. Furthermore, iGOF–Perturb-seq performed in a mouse neuroinflammatory model identified Ferd3l as a therapeutic candidate, and astrocyte-specific overexpression of Ferd3l alleviated Alzheimer’s disease symptoms in mice. This study provides resources for understanding gene regulation and disease mechanisms in vivo and for identifying potential therapeutic targets for different brain diseases.